Improved outcome of patients with relapsed/refractory Hodgkin lymphoma with a new fotemustine‐based high‐dose chemotherapy regimen

High‐dose chemotherapy (HDT) with autologous stem cell transplantation is the standard of care for relapsed/refractory (RR) Hodgkin lymphoma (HL). Given that HDT may cure a sizeable proportion of patients refractory to first salvage, development of newer conditioning regimens remains a priority. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Musso, Maurizio, Messina, Giuseppe, Di Renzo, Nicola, Di Carlo, Paolo, Vitolo, Umberto, Scalone, Renato, Marcacci, Gianpaolo, Scalzulli, Potito R., Moscato, Tiziana, Matera, Rossella, Crescimanno, Alessandra, Santarone, Stella, Orciuolo, Enrico, Merenda, Anxur, Pavone, Vincenzo, Pastore, Domenico, Donnarumma, Daniela, Carella, Angelo M., Ciochetto, Chiara, Cascavilla, Nicola, Mele, Anna, Lanza, Francesco, Di Nicola, Massimo, Bonizzoni, Erminio, Pinto, Antonello
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Haematological Malignancy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053328/
https://www.ncbi.nlm.nih.gov/pubmed/26458240
http://dx.doi.org/10.1111/bjh.13803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053328/
https://www.ncbi.nlm.nih.gov/pubmed/26458240
http://dx.doi.org/10.1111/bjh.13803

Ejemplares similares